
Ep112: Bernat Olle on Microbiome Therapeutics
The Long Run with Luke Timmerman
How Much Bacteria Is Enough?
Last fall you presented some what looked to be pretty encourage in phase two data in c dif a infections f. Can you talk a little bit about your lead candidate, because i know last fall you a presented some what looks to be pretty encouraging in phase twodata in c d if a infectionsf. Could you say a littlebit about what's in that product and whats what are its properties? And the in the trial. This is the fine construction of a different species of bacteria that are commentas a cin leavin the human intestion. Then we selecte bason, the ability too close trederls difficile, which is the pathagon they we're trying
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.